David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 11.33% |
| 4 | Financials | 7.58% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CJ
2276
DELISTED
C&J Energy Services, Inc.
CJ
| $1.63M | ﹤0.01% |
120,655
-290,163
| -71% | -$5.18M |
|
2277
PUT
Okta
OKTA
$22.4B
| $1.63M | ﹤0.01% |
25,500
+22,600
| +779% | +$1.34M |
|
|
WBC
2278
DELISTED
WABCO HOLDINGS INC.
WBC
| $1.63M | ﹤0.01% |
15,148
-97,573
| -87% | -$10.8M |
|
2279
Sportsman's Warehouse
SPWH
$45.3M
| $1.62M | ﹤0.01% |
370,434
+85,955
| +30% | +$418K |
|
|
DF
2280
DELISTED
Dean Foods Company
DF
| $1.62M | ﹤0.01% |
426,091
+3,185
| +0.8% | +$19.2K |
|
2281
PUT
APA Corp
APA
$14.6B
| $1.62M | ﹤0.01% |
61,800
-41,200
| -40% | -$1.52M |
|
|
EPAY
2282
DELISTED
Bottomline Technologies Inc
EPAY
| $1.62M | ﹤0.01% |
33,714
-5,463
| -14% | -$316K |
|
2283
CONMED
CNMD
$1.51B
| $1.62M | ﹤0.01% |
25,203
+21,778
| +636% | +$1.49M |
|
|
SAFM
2284
PUT
DELISTED
Sanderson Farms Inc
SAFM
| $1.62M | ﹤0.01% |
16,300
-21,400
| -57% | -$2.19M |
|
|
BDSI
2285
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.62M | ﹤0.01% |
437,129
+275,894
| +171% | +$969K |
|
2286
PUT
Baker Hughes
BKR
$61.9B
| $1.61M | ﹤0.01% |
+75,000
| New | +$1.92M |
|
2287
DHI Group
DHX
$188M
| $1.61M | ﹤0.01% |
1,060,801
-40,174
| -4% | -$69.4K |
|
2288
Essential Properties Realty Trust
EPRT
$6.61B
| $1.61M | ﹤0.01% |
+116,493
| New | +$1.62M |
|
|
TIF
2289
PUT
DELISTED
Tiffany & Co.
TIF
| $1.61M | ﹤0.01% |
20,000
-1,300
| -6% | -$132K |
|
2290
Stanley Black & Decker
SWK
$15B
| $1.61M | ﹤0.01% |
13,433
-3,958
| -23% | -$494K |
|
|
TAST
2291
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.61M | ﹤0.01% |
163,375
-70,097
| -30% | -$837K |
|
2292
CALL
Oxford Industries
OXM
$569M
| $1.61M | ﹤0.01% |
22,600
| – | – |
|
2293
Natera
NTRA
$49B
| $1.6M | ﹤0.01% |
114,952
-51,732
| -31% | -$945K |
|
|
SBNY
2294
PUT
DELISTED
Signature Bank
SBNY
| $1.6M | ﹤0.01% |
15,600
-3,900
| -20% | -$439K |
|
|
PBPB
2295
DELISTED
Potbelly
PBPB
| $1.6M | ﹤0.01% |
199,074
+5,360
| +3% | +$57.5K |
|
2296
Luxfer Holdings
LXFR
$459M
| $1.6M | ﹤0.01% |
+90,682
| New | +$2.06M |
|
|
SBBP
2297
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.59M | ﹤0.01% |
355,874
+168,243
| +90% | +$821K |
|
|
AMTD
2298
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.59M | ﹤0.01% |
32,513
-536,033
| -94% | -$27.3M |
|
|
OTIC
2299
DELISTED
Otonomy, Inc.
OTIC
| $1.59M | ﹤0.01% |
859,838
-38,166
| -4% | -$90K |
|
2300
Karyopharm Therapeutics
KPTI
$42.9M
| $1.59M | ﹤0.01% |
11,311
-3,573
| -24% | -$603K |
|
Similar funds
David Shaw's Q4 2018 Portfolio in Review
As of Q4 2018, David Shaw held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
David Shaw deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- David Shaw's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- David Shaw added most to Oracle in Q4 2018, an estimated $431M increase.
- David Shaw's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- David Shaw fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- David Shaw's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- David Shaw opened 541 new positions and closed 497 in Q4 2018.
- David Shaw's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.